Publikationen von A Power

Gündüz, S.; Power, A.; Maier, M.; Logothetis, N.; Angelovski, G.: Synthesis and Characterization of a Biotinylated Multivalent Targeted Contrast Agent. ChemPlusChem 80 (3), S. 612 - 622 (2015)

Hagberg, G.; Mamedov, I.; Power, A.; Beyerlein, M.; Merkle, H.; Kiselev, V.; Dhingra, K.; Kubiček, V.; Angelovski, G.; Logothetis, N.: Diffusion properties of conventional and calcium-sensitive MRI contrast agents in the rat cerebral cortex. Contrast Media Molecular Imaging 9 (1), S. 71 - 82 (2014)

Power, A.; Bell, J.: Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy. Gene Therapy 15 (10), S. 772 - 779 (2008)

Goel, A.; Carlson, S.; Classic, K.; Greiner, S.; Power, A.; Bell, J.; Russell, S.: Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood 110 (7), S. 2342 - 2350 (2007)

Power, A.; Bell, J.: Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer. Molecular Therapy 15 (4), S. 660 - 665 (2007)

Power, A.; Wang , J.; Falls, T.; Paterson, J.; Parato, K.; Lichty, B.; Stojdl, D.; Forsyth, P.; Atkins, H.; Bell, J.: Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity. Molecular Therapy 15 (1), S. 123 - 130 (2007)

Lun, X.; Senger, D.; Alain, T.; Oprea, A.; Parato, K.; Stojdl, D.; Lichty, B.; Power, A.; Johnston , R.; Hamilton, M. et al.; Parney, I.; Bell, J.; Forsyth, P.: Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas. Journal of the National Cancer Institute 98 (21), S. 1546 - 1557 (2006)

Lichty, B.; Power, A.; Stojdl, D.; Bell, J.: Vesicular stomatitis virus: re-inventing the bullet. Trends in Molecular Medicine 10 (5), S. 210 - 216 (2004)

Gündüz, S.; Power, A.; Logothetis, N. K.; Angelovski, G.: Synthesis of High Affinity Agents for Targeted MR Neuroimaging. COST Action CM1006: European f-Element Chemistry: EUFEN 3, Nürnberg, Germany (2014)

Gündüz, S.; Power, A.; Logothetis, N. K.; Angelovski, G.: Synthesis of High Affinity Agents for Targeted MR Neuroimaging. COST Action CM1006: European f-Element Chemistry: EUFEN 3, Nürnberg, Germany (2014)

Gunduz, S.; Power, A.; Logothetis, N.; Angelovski, G.: Synthesis of High Affinity Contrast Agents for Targeted MR Neuroimaging. COST TD1004 Action: Theranostics Imaging and Therapy: An Action to Develop Novel Nanosized Systems for Imaging: Guided Drug Delivery, Athens, Greece (2013)

Hagberg, G.; Mamedov, I.; Power, A.; Beyerlein, M.; Merkle, H.; Dhingra, K.; Kubicek, V.; Logothetis, N.: Diffusion of conventional and calcium sensitive MRI contrast agents in the rat cerebral cortex. Fifth Annual World Molecular Imaging Congress (WMIC 2012), Dublin, Ireland (2012)

Klein, C.; Evrard, H.; Power, A.; Boyden, E.; Logothetis, N.; Schmid, M.: Optogenetics in the macaque thalamus. 7th Brain Research Conference “Optogenetics and Pharmacogenetics in Neuronal Function and Dysfunction”, New Orleans, LA, USA (2012)

Klein, C.; Evrard, H.; Power, A.; Monosov, I.; Boyden, E.; Logothetis, N.; Schmid, M.: Optogenetics in the macaque thalamus. 42nd Annual Meeting of the Society for Neuroscience (Neuroscience 2012), New Orleans, LA, USA (2012)

Hagberg, G.; Mamedov, I.; Power, A.; Beyerlein, M.; Merkle, H.; Angelovski, G.; Logothetis, N.: Diffusion in the extra-cellular space of the rat cerebral cortex probed by MRI and direct infusion of contrast agents. 20th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2012), Melbourne, Australia (2012)